Blood, Vol. 115, Issue 25, 5232-5240, June 24, 2010 CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms Supplemental materials for: Tyner et alFiles in this Data Supplement: |